• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Livanova Unveils 2025 Results, Provides 2026 Guidance

    BUSINESSWIRE

    Livanova To Announce Fourth-Quarter And Full-Year 2025 Results

    BUSINESSWIRE

    Livanova To Present At J.P. Morgan Health Conf In January

    BUSINESSWIRE

    LivaNova Showcases CORE-VNS Study Data At AES 2025 Meeting

    BUSINESSWIRE

    Livanova Names Lucile Blaise Global Commercialization Head

    BUSINESSWIRE

    LivaNova to Present at Piper Sandler Healthcare Conference

    BUSINESSWIRE

    CMS Boosts LivaNova VNS Coverage for Refractory Epilepsy

    BUSINESSWIRE

    Livanova Reports Third-Quarter 2025 Results; Raises 2025 Guidance

    BUSINESS WIRE

    Livanova To Present at Wolfe Research Healthcare Conference

    BUSINESSWIRE

    Livanova To Announce Third-Quarter 2025 Results

    BUSINESSWIRE

    LivaNova Appoints Donald Zurbay as a New Director

    BUSINESSWIRE

    LivaNova to Host Investor Day on November 12, 2025

    BUSINESSWIRE

    LivaNova Announces Q2 2025 Results

    BUSINESSWIRE

    LivaNova CORE-VNS Data Show Big Seizure Drop at 24 Months

    BUSINESSWIRE

    LivaNova Seeks CMS Reconsideration for VNS Therapy in Depression

    BUSINESSWIRE

    LivaNova to Present at the Jefferies Global Healthcare Conference

    BUSINESSWIRE

    LivaNova Announces 12-month Data from OSPREY Study on Sleep Apnea

    BUSINESSWIRE

    LivaNova Updates On RECOVER VNS Therapy Depression Study

    BUSINESSWIRE

    LivaNova Provides Update On RECOVER VNS Therapy Depression Study

    BUSINESSWIRE

    LivaNova Announces a Positive Outcome of Trial of OSPREY for Sleep Apnea

    BUSINESSWIRE

    LivaNova offers fix for recalled life support pump controllers

    FIERCE BIOTECH

    FDA classifies recall of LivaNova`s blood-pumping system controller as most serious

    REUTERS

    LivaNova and Verily Announce First Patient Enrolled in Study to Effectiveness

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.